Patents by Inventor Gavin Oudit

Gavin Oudit has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • APELIN PEPTIDES AND USES THEREOF
    Publication number: 20200239537
    Abstract: The disclosure relates to modified apelin polypeptides having increased stability against kallikrein, NEP and ACE2 degradation and/or potency relative to the native apelin-13 and apelin-17 polypeptides. Embodiments also disclose methods of using the polypeptides for treating cardiovascular disorders.
    Type: Application
    Filed: March 16, 2020
    Publication date: July 30, 2020
    Inventors: Gavin OUDIT, John VEDERAS, Shaun MCKINNIE, Conrad FISCHER
  • Apelin peptides and uses thereof
    Patent number: 10723776
    Abstract: The disclosure relates to modified apelin polypeptides having increased stability against kallikrein, NEP and ACE2 degradation and/or potency relative to the native apelin-13 and apelin-17 polypeptides. Embodiments also disclose methods of using the polypeptides for treating cardiovascular disorders.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: July 28, 2020
    Assignee: THE GOVERNERS OF THE UNIVERSITY OF ALBERTA
    Inventors: Gavin Oudit, John Vederas, Shaun McKinnie, Conrad Fischer
  • Apelin peptides and uses thereof
    Patent number: 10640545
    Abstract: The disclosure relates to modified apelin polypeptides having increased stability against kallikrein, NEP and ACE2 degradation and/or potency relative to the native apelin-13 and apelin-17 polypeptides. Embodiments also disclose methods of using the polypeptides for treating cardiovascular disorders.
    Type: Grant
    Filed: July 3, 2018
    Date of Patent: May 5, 2020
    Assignee: THE GOVERNORS OF THE UNIV OF ALBERTA TEC EDMONTON
    Inventors: Gavin Oudit, John Vederas, Shaun McKinnie, Conrad Fischer
  • APELIN PEPTIDES AND USES THEREOF
    Publication number: 20190010202
    Abstract: The disclosure relates to modified apelin polypeptides having increased stability against kallikrein, NEP and ACE2 degradation and/or potency relative to the native apelin-13 and apelin-17 polypeptides. Embodiments also disclose methods of using the polypeptides for treating cardiovascular disorders.
    Type: Application
    Filed: July 3, 2018
    Publication date: January 10, 2019
    Inventors: Gavin OUDIT, John VEDERAS, Shaun MCKINNIE, Conrad FISCHER
  • BIOMARKERS FOR ANDERSON-FABRY DISEASE
    Publication number: 20170205427
    Abstract: Disclosed herein is a method for screening and diagnosis of Anderson-Fabry Disease in a subject based on biomarker expression in patient samples. Also disclosed are computer systems, kits, and software for implementation of the biomarkers.
    Type: Application
    Filed: July 22, 2015
    Publication date: July 20, 2017
    Inventors: Michael L. West, Gavin Oudit, Bruce M. McManus, Zsuzsanna Hollander